Navigating New U.S. Onshoring & Pharmaceutical Tariff Developments
A Q&A with Kenneth Bilenberg, Group President & CEO of Avid Bioservices Recently, the U.S. Department of Commerce released procedures allowing pharmaceutical companies to apply for company-specific tariff adjustments tied to U.S. onshoring commitments […]
Corporate Capabilities Brochure
The Power of “What if”
By Nicholas Green, President & CEO We completely transformed the CDMO experience — and the effect is life-changing. Avid Bioservices’ founders have been inspired by the spirit of discovery at […]
Mammalian Protein DS Line 2 Tour
Mammalian Protein DS Line 3 Tour
Scale-Up Expertise to Support Your Biologics Lifecycle
A Strategic Approach to Pre-License Inspections
Expanding and Serving the Market with Flexible Single-Use Capacity
Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status
Unique Commercial Experience Primes Avid Bioservices for Growth
